Search for Clinical Trial Results
Bone Cysts - 25 Studies Found
Status | Study |
Enrolling by invitation |
Study Name: Osteoconduction Potential of an Injectable Calcium Phosphate in Orthopaedic Surgery in Fillings of Osseous Defects Condition: Grafting, Bone Date: 2005-09-12 Interventions: Device: MBCP-Gel (tm) |
Completed |
Study Name: Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face Condition: Neoplastic Syndrome Date: 2007-06-20 Interventions: Drug: tazarotene Tazarotene is a member of the acetylenic class of retinoids. |
Completed |
Study Name: Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back Condition: Skin Carcinoma Date: 2008-10-31 Interventions:
|
Withdrawn |
Study Name: Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) Condition: Basal Cell Carcinoma Date: 2010-07-06 Interventions:
|
Recruiting |
Study Name: Familial Investigations of Childhood Cancer Predisposition Condition:
|
Completed |
Study Name: Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas (BCC) in Gorlin Syndrome Patients Condition: Basal Cell Nevus Syndrome Date: 2016-04-27 Interventions:
|
Recruiting |
Study Name: Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas Condition: Basal Cell Carcinoma Date: 2015-12-14 Interventions: Drug: Vismodegib Vismodegib 150 mgs po qd for 3 months |
Recruiting |
Study Name: A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma Condition:
|
Recruiting |
Study Name: Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS) Condition: Basal Cell Carcinoma in Basal Cell Nevus Syndrome Date: 2015-01-21 Interventions: Drug: SUBA-Itraconazole Subjects will receive an oral dose of 300 mg SUBA-Itraconazole daily. |
Active, not recruiting |
Study Name: Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma Condition:
|